This site is intended for healthcare professionals
Type 2 Inflammation in Gastroenterology ADVENTprogram.com banner
Type 2 Inflammation in Gastroenterology
Declaration of sponsorship Sanofi and Regeneron

Adult Eosinophilic Esophagitis

Declaration of sponsorship Sanofi and Regeneron
Read time: 80 mins
Last updated:28th Aug 2024
Published:15th Nov 2023

Eosinophilic esophagitis is a chronic, progressive disease primarily driven by type 2 inflammation and characterized by remodeling in the esophagus, dysphagia, food impaction, and/or significant patient burden1-3

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

GEO restriction imageThis resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Gastroenterology resources

Welcome: